Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease
- PMID: 34387614
- PMCID: PMC8382476
- DOI: 10.1097/CM9.0000000000001720
Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease
Conflict of interest statement
None.
References
-
- Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE, et al. . Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv 2012; 5:476–490. doi: 10.1161/CIRCINTERVENTIONS.112.970954. - PubMed
-
- Ardati AK, Pitt B, Smith DE, Aronow HD, Share D, Moscucci M, et al. . Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention. Am Heart J 2013; 165:778–784. doi: 10.1016/j.ahj.2013.01.015. - PubMed
-
- Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, et al. . Authors/Task Force Members. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541–2619. doi: 10.1093/eurheartj/ehu278. - PubMed
-
- Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. . Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355:1575–1581. doi: 10.1016/s0140-6736(00)02212-1. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical